FI113473B - Menetelmä ergoliinijohdannaisten valmistamiseksi - Google Patents

Menetelmä ergoliinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI113473B
FI113473B FI934933A FI934933A FI113473B FI 113473 B FI113473 B FI 113473B FI 934933 A FI934933 A FI 934933A FI 934933 A FI934933 A FI 934933A FI 113473 B FI113473 B FI 113473B
Authority
FI
Finland
Prior art keywords
group
formula
process according
alkyl
hydrogen
Prior art date
Application number
FI934933A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934933A7 (fi
FI934933A0 (fi
Inventor
Angelo Bedeschi
Franco Zarini
Walter Cabri
Ilaria Candiani
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of FI934933A7 publication Critical patent/FI934933A7/fi
Publication of FI934933A0 publication Critical patent/FI934933A0/fi
Application granted granted Critical
Publication of FI113473B publication Critical patent/FI113473B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Electric Motors In General (AREA)
  • Emergency Protection Circuit Devices (AREA)
FI934933A 1992-03-12 1993-11-08 Menetelmä ergoliinijohdannaisten valmistamiseksi FI113473B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929205439A GB9205439D0 (en) 1992-03-12 1992-03-12 Process for the synthesis of ergoline derivatives
GB9205439 1992-03-12
PCT/EP1993/000360 WO1993018034A1 (en) 1992-03-12 1993-02-15 Process for the preparation of ergoline derivatives
EP9300360 1993-02-15

Publications (3)

Publication Number Publication Date
FI934933A7 FI934933A7 (fi) 1993-11-08
FI934933A0 FI934933A0 (fi) 1993-11-08
FI113473B true FI113473B (fi) 2004-04-30

Family

ID=10712024

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934933A FI113473B (fi) 1992-03-12 1993-11-08 Menetelmä ergoliinijohdannaisten valmistamiseksi

Country Status (25)

Country Link
US (1) US5382669A (cs)
EP (1) EP0593692B1 (cs)
JP (1) JP3339858B2 (cs)
KR (1) KR100274102B1 (cs)
CN (1) CN1038510C (cs)
AT (1) ATE180783T1 (cs)
AU (1) AU653099B2 (cs)
CA (1) CA2106371C (cs)
CZ (1) CZ281708B6 (cs)
DE (1) DE69325138D1 (cs)
FI (1) FI113473B (cs)
GB (1) GB9205439D0 (cs)
HU (1) HU210407B (cs)
IL (1) IL104973A (cs)
MX (1) MX9301297A (cs)
MY (1) MY109152A (cs)
NO (1) NO302754B1 (cs)
NZ (1) NZ249115A (cs)
PH (1) PH30138A (cs)
RU (1) RU2118323C1 (cs)
SK (1) SK279039B6 (cs)
TW (1) TW215089B (cs)
UA (1) UA26400C2 (cs)
WO (1) WO1993018034A1 (cs)
ZA (1) ZA931720B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
US6696568B2 (en) 2001-04-16 2004-02-24 Finetech Ltd. Process and intermediates for production of cabergoline and related compounds
RU2329273C2 (ru) * 2003-04-11 2008-07-20 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С. Химерные аналоги лигандов соматостатиновых и допаминовых рецепторов, фармацевтические композиции на их основе и способы воздействия на рецепторы соматостатина и/или допамина
IL155545A (en) * 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
HUP0400517A3 (en) * 2004-03-04 2006-05-29 Richter Gedeon Vegyeszet Process for producing cabergoline
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
FR2877945A1 (fr) * 2004-11-18 2006-05-19 Archemis Sa Procede de la preparation de la cabergoline
EP1858894A1 (en) 2005-03-17 2007-11-28 Synthon Argentina S.A. Improved process for making cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
US9670199B2 (en) 2012-11-19 2017-06-06 Regents Of The University Of Minnesota Ergoline derivatives as dopamine receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2074566B (en) * 1980-04-03 1983-11-02 Erba Farmitalia Ergoline derivatives
GB2103603B (en) * 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives

Also Published As

Publication number Publication date
WO1993018034A1 (en) 1993-09-16
HU210407B (en) 1995-04-28
IL104973A (en) 1997-06-10
JP3339858B2 (ja) 2002-10-28
CN1076196A (zh) 1993-09-15
SK140193A3 (en) 1994-11-09
NZ249115A (en) 1995-04-27
AU3497493A (en) 1993-10-05
EP0593692A1 (en) 1994-04-27
RU2118323C1 (ru) 1998-08-27
CZ281708B6 (cs) 1996-12-11
NO934077D0 (no) 1993-11-11
ZA931720B (en) 1993-11-01
CA2106371C (en) 2003-09-23
MX9301297A (es) 1993-09-01
MY109152A (en) 1996-12-31
AU653099B2 (en) 1994-09-15
NO934077L (no) 1993-11-11
KR100274102B1 (ko) 2000-12-15
NO302754B1 (no) 1998-04-20
TW215089B (cs) 1993-10-21
IL104973A0 (en) 1993-07-08
CA2106371A1 (en) 1993-09-13
CZ271593A3 (en) 1994-04-13
GB9205439D0 (en) 1992-04-22
JPH06507648A (ja) 1994-09-01
HUT66712A (en) 1994-12-28
ATE180783T1 (de) 1999-06-15
DE69325138D1 (de) 1999-07-08
UA26400C2 (uk) 1999-08-30
PH30138A (en) 1997-01-21
US5382669A (en) 1995-01-17
CN1038510C (zh) 1998-05-27
FI934933A7 (fi) 1993-11-08
FI934933A0 (fi) 1993-11-08
EP0593692B1 (en) 1999-06-02
SK279039B6 (sk) 1998-05-06

Similar Documents

Publication Publication Date Title
FI113473B (fi) Menetelmä ergoliinijohdannaisten valmistamiseksi
KR940004073B1 (ko) 라파마이신 전구체의 제조방법
EP0485218B1 (en) Process for preparing (1'R,3S)-3-(1'-hydroxy-ethyl)-azetidin-2-one and derivatives thereof
Esker et al. Multiple reaction channels of (N-Acyl-N-alkylcarbamoyl) oxyl radicals from N-acyl PTOC carbamates
GB2103603A (en) Ergoline derivatives
US4424167A (en) Process for the preparation of 2,3-dichlorosulphonyl-acrylonitriles
FI95262B (fi) Menetelmä uusien fosfolipidijohdannaisten valmistamiseksi
FI76556B (fi) Foerfarande foer framstaellande av treo-2- hydroxi-3-(4-methoxifenyl)-3- (2-nitrofenyltio)-propionsyreester.
DE68916908T2 (de) Carbapenemderivate.
岡田至 et al. Synthesis and acaricidal activity of bicyclic pyrazole-3-carboxamide derivatives
IL27897A (en) Preparation of pyrazinoalguanides and pyrazinoamidoguanidines
US4837349A (en) Tertiary-butyldimethylsilyl carbamate derivative and process for producing the same
US20020177709A1 (en) Novel process and intermediates for production of cabergoline and related compounds
EP0134615B1 (en) Process for preparing n-substituted nitromethylene heterocyclic compounds
IE911011A1 (en) NOVEL DERIVATIVES OF¹4H-PYRROLO[1,2-a]THIENO[2,3-f][1,4]DIAZEPINE THEIR PROCESS¹OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS¹CONTAINING THEM
JPS62207268A (ja) １，３−ジチオラン−２−チオン誘導体の製造方法
SU1214669A1 (ru) Способ получени 2-алкилроданинов
JPH0376313B2 (cs)
TH9178B (th) กรรมวิธีในการเตรียมอนุพันธ์เออร์โกลีน
TH13523A (th) กรรมวิธีในการเตรียมอนุพันธ์เออร์โกลีน
JPH04270288A (ja) チエノ〔２，３−ｂ〕インドリジン誘導体
JPH0674250B2 (ja) チオカルバメ−ト誘導体の製法
FR2590901A1 (fr) Procede de preparation de n-sulfonyl n-(phosphonomethyl-glycyl) amines utilisables comme herbicides
JPS63303990A (ja) １−有機チオグリコシル化合物の製造法
JPH0473427B2 (cs)

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.